Monovisc 88 MG/4 ML syringe 4ML

Ended Awarded

Contract number
SPE2DB25FQ1UV
Awardee
Awarding agency
Obligated
$2,876

Award facts

Contract value 100% obligated
$2,875.94 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML. The $2,875.94 firm fixed-price delivery order contract has an ultimate completion date of July 18, 2025. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, to supply a wide range of pharmaceutical products and medical supplies in support of military healthcare programs worldwide. This contract award is not designated as a set-aside.

Quick answers

Who was awarded contract SPE2DB25FQ1UV?

SPE2DB25FQ1UV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 17, 2025.

How much is contract SPE2DB25FQ1UV worth?

The government has obligated $2,876 on SPE2DB25FQ1UV.

Is contract SPE2DB25FQ1UV an order under another contract?

Yes. SPE2DB25FQ1UV is a delivery order under SPE2DB22D3011, an indefinite delivery contract.

Was contract SPE2DB25FQ1UV competed?

The extent of competition for SPE2DB25FQ1UV was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award